常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.42/-0.05
|
|
企業價值
1.66B
|
| 資產負債 |
|
每股賬面淨值
1.37
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
821.31M
|
|
每股收益
0.58
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2025/11/07 13:13 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol. |

1.215 
